Huapont Life Sciences Co Ltd Cash Flow Conversion Efficiency
Huapont Life Sciences Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Huapont Life Sciences Co Ltd (002004) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥635.17 Million ≈ $92.95 Million USD) by net assets (CN¥16.10 Billion ≈ $2.36 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Huapont Life Sciences Co Ltd (2002–2025)
Cash flow conversion efficiency of Huapont Life Sciences Co Ltd from 2002 to 2025. This chart illustrates how Huapont Life Sciences Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Huapont Life Sciences Co Ltd (002004) share price today for real-time trading data and today's change.
Huapont Life Sciences Co Ltd Cash Flow Conversion Ratio Explained
Huapont Life Sciences Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Huapont Life Sciences Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huapont Life Sciences Co Ltd ranked by their cash flow conversion efficiency. Also see 002004 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
0.009x |
|
Azenta Inc
NASDAQ:AZTA
|
0.002x |
|
Shenzhen Edadoc Technology Co. Ltd. A
SHE:301366
|
N/A |
|
Godawari Power And Ispat limited
NSE:GPIL
|
0.076x |
|
Siglent Technologies Co Ltd
SHG:688112
|
0.023x |
|
Lotus Pharmaceutical Co Ltd
TW:1795
|
0.029x |
|
WIN Semiconductors
TWO:3105
|
-0.020x |
|
East Group Co Ltd
SHE:300376
|
0.098x |
Annual Cash Flow Conversion Efficiency for Huapont Life Sciences Co Ltd (2002–2025)
The table below shows the annual cash flow conversion efficiency of Huapont Life Sciences Co Ltd from 2002 to 2025. Review Huapont Life Sciences Co Ltd (002004) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥16.98 Billion ≈ $2.48 Billion |
CN¥2.10 Billion ≈ $306.72 Million |
0.123x | +17.53% |
| 2024-12-31 | CN¥15.47 Billion ≈ $2.26 Billion |
CN¥1.63 Billion ≈ $237.83 Million |
0.105x | +9.60% |
| 2023-12-31 | CN¥16.58 Billion ≈ $2.43 Billion |
CN¥1.59 Billion ≈ $232.59 Million |
0.096x | -34.12% |
| 2022-12-31 | CN¥16.55 Billion ≈ $2.42 Billion |
CN¥2.41 Billion ≈ $352.34 Million |
0.145x | +81.32% |
| 2021-12-31 | CN¥15.82 Billion ≈ $2.32 Billion |
CN¥1.27 Billion ≈ $185.79 Million |
0.080x | -52.20% |
| 2020-12-31 | CN¥14.14 Billion ≈ $2.07 Billion |
CN¥2.37 Billion ≈ $347.20 Million |
0.168x | +6.76% |
| 2019-12-31 | CN¥13.24 Billion ≈ $1.94 Billion |
CN¥2.08 Billion ≈ $304.68 Million |
0.157x | +5.02% |
| 2018-12-31 | CN¥12.75 Billion ≈ $1.87 Billion |
CN¥1.91 Billion ≈ $279.29 Million |
0.150x | +236.59% |
| 2017-12-31 | CN¥13.30 Billion ≈ $1.95 Billion |
CN¥591.40 Million ≈ $86.54 Million |
0.044x | -6.99% |
| 2016-12-31 | CN¥10.70 Billion ≈ $1.57 Billion |
CN¥511.90 Million ≈ $74.91 Million |
0.048x | +45.38% |
| 2015-12-31 | CN¥10.41 Billion ≈ $1.52 Billion |
CN¥342.45 Million ≈ $50.11 Million |
0.033x | -58.65% |
| 2014-12-31 | CN¥5.73 Billion ≈ $838.76 Million |
CN¥455.96 Million ≈ $66.72 Million |
0.080x | -8.68% |
| 2013-12-31 | CN¥4.01 Billion ≈ $587.13 Million |
CN¥349.51 Million ≈ $51.14 Million |
0.087x | -0.07% |
| 2012-12-31 | CN¥2.96 Billion ≈ $432.69 Million |
CN¥257.75 Million ≈ $37.72 Million |
0.087x | +66.69% |
| 2011-12-31 | CN¥2.59 Billion ≈ $378.40 Million |
CN¥135.23 Million ≈ $19.79 Million |
0.052x | -32.16% |
| 2010-12-31 | CN¥1.04 Billion ≈ $151.57 Million |
CN¥79.84 Million ≈ $11.68 Million |
0.077x | -44.01% |
| 2009-12-31 | CN¥897.32 Million ≈ $131.31 Million |
CN¥123.53 Million ≈ $18.08 Million |
0.138x | -1.49% |
| 2008-12-31 | CN¥814.07 Million ≈ $119.12 Million |
CN¥113.76 Million ≈ $16.65 Million |
0.140x | +28.94% |
| 2007-12-31 | CN¥730.86 Million ≈ $106.95 Million |
CN¥79.21 Million ≈ $11.59 Million |
0.108x | -14.27% |
| 2006-12-31 | CN¥522.90 Million ≈ $76.52 Million |
CN¥66.10 Million ≈ $9.67 Million |
0.126x | +27.50% |
| 2005-12-31 | CN¥440.68 Million ≈ $64.49 Million |
CN¥43.69 Million ≈ $6.39 Million |
0.099x | -43.60% |
| 2004-12-31 | CN¥401.64 Million ≈ $58.77 Million |
CN¥70.60 Million ≈ $10.33 Million |
0.176x | -54.80% |
| 2003-12-31 | CN¥145.74 Million ≈ $21.33 Million |
CN¥56.68 Million ≈ $8.29 Million |
0.389x | +7.74% |
| 2002-12-31 | CN¥102.18 Million ≈ $14.95 Million |
CN¥36.88 Million ≈ $5.40 Million |
0.361x | -- |
About Huapont Life Sciences Co Ltd
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. It is involved in the production and sale of pharmaceutical preparations and raw materials. The company also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management… Read more